Mitoxantrone Recruiting Phase 2 Trials for Pediatric Acute Myeloid Leukemia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02848183Optimal Treatment Strategy Based on for Pediatric AML